Core Laboratories (CLB) Debt to Equity (2022 - 2025)
Core Laboratories' Debt to Equity history spans 4 years, with the latest figure at $0.41 for Q4 2025.
- For Q4 2025, Debt to Equity fell 20.81% year-over-year to $0.41; the TTM value through Dec 2025 reached $0.41, down 20.81%, while the annual FY2025 figure was $0.41, 20.81% down from the prior year.
- Debt to Equity reached $0.41 in Q4 2025 per CLB's latest filing, down from $0.42 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.94 in Q4 2022 to a low of $0.41 in Q4 2025.
- Average Debt to Equity over 4 years is $0.61, with a median of $0.57 recorded in 2024.
- Peak YoY movement for Debt to Equity: fell 29.65% in 2024, then decreased 20.81% in 2025.
- A 4-year view of Debt to Equity shows it stood at $0.94 in 2022, then dropped by 22.6% to $0.73 in 2023, then dropped by 29.65% to $0.51 in 2024, then fell by 20.81% to $0.41 in 2025.
- Per Business Quant, the three most recent readings for CLB's Debt to Equity are $0.41 (Q4 2025), $0.42 (Q3 2025), and $0.47 (Q2 2025).